Circulating cell-free placental mRNA in the maternal plasma as a predictive marker for twin-twin transfusion syndrome [7]

Clinical Chemistry

Volumn 53, Issue 6, 2007, Pages 1167-1168

  Miura, Kiyonori ^a,c   Yamasaki, Kentaro ^a   Miura, Shoko ^a,b   Yoshiura, Koh Ichiro ^a,b   Shimada, Takako ^a   Nakayama, Daisuke ^a   Niikawa, Norio ^a,b   Masuzaki, Hideaki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PLACENTA PROTEIN;

BLOOD SAMPLING; CELL FREE SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; LETTER; MATERNAL PLASMA; NON INVASIVE MEASUREMENT; PLACENTA CIRCULATION; PREGNANCY COMPLICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TWIN TWIN TRANSFUSION SYNDROME;

BIOLOGICAL MARKERS; FEMALE; FETOFETAL TRANSFUSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; PLACENTA; PLACENTAL LACTOGEN; PREDICTIVE VALUE OF TESTS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34249885362     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.087890     Document Type: Letter

References (5)

1. Quintero RA, Morales WJ, Allen MH, Bomick PW, Johnson PK, Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol 1999;19:550-5.
2. Jain V, Fisk NM. The twin-twin transfusion syndrome. Clin Obstet Gynecol 2004;47:181-202.
3. Dennis Lo YM, Chiu RW. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genat 2007;8:71-7.
4. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A 2003;100:4748-53.
5. Purwosunu Y, Sekizawa A, Koide K, Farina A, Wibowo N, Wiknjosastro GH, et al. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plssma of pregnant women with preeclampsia. Clin Chem 2007;53:399-404.